 - To submit sera from selected subjects to the Center for Biologics Evaluation and Research CBER for further analysis by the World Health Organization WHO, the Centers for Disease Control and Prevention CDC, and the Food and Drug Administration FDA to support formulation recommendations for subsequent influenza vaccines. 